TD SYNNEX (SNX) director sells 870 shares at $158.65
TD SYNNEX director and officer Dennis Polk reported a non-derivative sale of 870 shares of common stock on 10/07/2025 at a price of $158.65 per share.
Rhea-AI Filing Summary
TD SYNNEX director and officer Dennis Polk reported a non-derivative sale of 870 shares of common stock on 10/07/2025 at a price of $158.65 per share. After the sale he directly beneficially owns 31,117 shares and indirectly owns 81,660 shares through a trust, showing continued significant aggregate holdings while executing a small disposition. The form was signed by an attorney-in-fact on 10/09/2025.
Positive
- Transparency maintained through timely Form 4 filing signed on 10/09/2025
- Significant aggregate ownership remains: 31,117 direct + 81,660 indirect shares
Negative
- Insider sale of 870 shares at $158.65 reduced direct holdings
Insights
Small insider sale, but substantial aggregate holdings remain.
The reported transaction is a routine non-derivative sale of 870 shares at $158.65 on 10/07/2025
Such sales can be for personal-liquidity reasons; the combination of 31,117 direct and 81,660 indirect shares indicates continued alignment with shareholders. Watch for further Form 4 filings within the next quarter for any trend in net disposals.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 870 | $158.65 | $138K |
| holding | Common Stock | -- | -- | -- |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Dennis Polk report on the Form 4 for SNX?
When was the Form 4 filed or signed?
Was the reported transaction a derivative or non-derivative trade?
Does the filing indicate any trading plan or 10b5-1 election?
AI-generated analysis. How Rhea-AI works. Not financial advice.